Information on new approvals and medication safety that rheumatologists need to know
Rheumatology Drug Updates
Information on new approvals and medication safety that rheumatologists need to know
Rheumatology Drug Updates
Information on new approvals and medication safety that rheumatologists need to know
Drug Updates: Lorcaserin, Acetaminophen, and More
information on new approvals and medication safety
Drug Updates: Citalopram hydrobromide, Statins, and More
Information on new approvals and medication safety
Biosimilar Drugs Face Challenges to Reach the U.S. Market
To date, the FDA has not approved a biosimilar product. In its own discussion of the merits and obstacles to biosimilar drugs, the ACR sponsored a panel session titled, “Biosimilar Products in the U.S. Market: Fact or Fiction?” at the 2011 ACR/ARHP Annual Scientific Meeting here in November.
Drug Updates: Apremilast, Belimumab, and More
Information on new approvals and medication safety
Clinical Trials Go Global
As medical research expands to the global population, will trial results sill apply to U.S. populations?
Drug Updates
Information on new approvals and medication safety
Drug Updates
Information on new approvals and medication safety